UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 144

Sortiert nach

beängstigend und Wunderbar Zugleich: Erschütternde Ereignisse und Die Religionsaffinität der Neuen Erlebnisweise

Stahl, Mirjam

1. Aufl. 2022 edition., 2022

Volltextzugriff (PDF)

Die Goldenen Zwanziger der Mukoviszidose

CME (Berlin, Germany), 2023-12, Vol.20 (12), p.73-85

Stahl, Mirjam

2023

Volltextzugriff (PDF)

Magnetic Resonance Imaging Detects Changes in Structure and Perfusion, and Response to Therapy in Early Cystic Fibrosis Lung Disease

American journal of respiratory and critical care medicine, 2014-04, Vol.189 (8), p.956-965

2014

Volltextzugriff (PDF)

Lung collagens perpetuate pulmonary fibrosis via CD204 and M2 macrophage activation

PloS one, 2013-11, Vol.8 (11), p.e81382-e81382

2013

Volltextzugriff (PDF)

Comparison of microbiomes from different niches of upper and lower airways in children and adolescents with cystic fibrosis

PloS one, 2015-01, Vol.10 (1), p.e0116029-e0116029

2015

Volltextzugriff (PDF)

Sensitive markers to detect progression of lung disease in children with cystic fibrosis

The European respiratory journal, 2021-07, Vol.58 (1), p.2100236

Stahl, Mirjam

2021

Volltextzugriff (PDF)

Chronic but not intermittent infection with Pseudomonas aeruginosa is associated with global changes of the lung microbiome in cystic fibrosis

The European respiratory journal, 2017-10, Vol.50 (4), p.1701086-1701086

2017

Volltextzugriff (PDF)

What to expect of the first ERS/ECFS Adult Cystic Fibrosis Conference

Breathe (Lausanne, Switzerland), 2023-09, Vol.19 (3), p.230152-230152

2023

Volltextzugriff (PDF)

Antigen specificity and cross-reactivity drive functionally diverse anti-Aspergillus fumigatus T cell responses in cystic fibrosis

The Journal of clinical investigation, 2023-03, Vol.133 (5)

2023

Volltextzugriff (PDF)

Quantification of Phenotypic Variability of Lung Disease in Children with Cystic Fibrosis

Genes, 2021-05, Vol.12 (6), p.803

2021

Volltextzugriff (PDF)

The value of chest magnetic resonance imaging compared to chest radiographs with and without additional lung ultrasound in children with complicated pneumonia

PloS one, 2020, Vol.15 (3), p.e0230252-e0230252

2020

Volltextzugriff (PDF)

A multi-centre, randomized, controlled trial on coaching and telemonitoring in patients with cystic fibrosis: conneCT CF

BMC pulmonary medicine, 2021-04, Vol.21 (1), p.131-131, Article 131

2021

Volltextzugriff (PDF)

Sustained Improvement of Cystic Fibrosis Lung Disease following Initiation of Elexacaftor/Tezacaftor/Ivacaftor Therapy: Lessons from Real-World Studies

American journal of respiratory and critical care medicine, 2023-11, Vol.208 (9), p.911

2023

Volltextzugriff (PDF)

Changes in Microbiome Dominance Are Associated With Declining Lung Function and Fluctuating Inflammation in People With Cystic Fibrosis

Frontiers in microbiology, 2022-05, Vol.13, p.885822-885822

2022

Volltextzugriff (PDF)

Effects of lumacaftor-ivacaftor therapy on cystic fibrosis transmembrane conductance regulator function in F508del homozygous patients with cystic fibrosis aged 2-11 years

Frontiers in pharmacology, 2023-05, Vol.14, p.1188051-1188051

2023

Volltextzugriff (PDF)

Valsalva purpura after gastroscopy

Deutsches Ärzteblatt international, 2024-05

2024

Volltextzugriff (PDF)

Long-term effects of lumacaftor/ivacaftor on paranasal sinus abnormalities in children with cystic fibrosis detected with magnetic resonance imaging

Frontiers in pharmacology, 2023-04, Vol.14, p.1161891-1161891

2023

Volltextzugriff (PDF)

A Volatile and Dynamic Longitudinal Microbiome Is Associated With Less Reduction in Lung Function in Adolescents With Cystic Fibrosis

Frontiers in cellular and infection microbiology, 2021-12, Vol.11, p.763121-763121

2021

Volltextzugriff (PDF)

Comparison of Oropharyngeal Microbiota from Children with Asthma and Cystic Fibrosis

Mediators of inflammation, 2017-01, Vol.2017, p.5047403-10

2017

Volltextzugriff (PDF)

CFTR Modulator Therapy with Lumacaftor/Ivacaftor Alters Plasma Concentrations of Lipid-Soluble Vitamins A and E in Patients with Cystic Fibrosis

Antioxidants, 2021-03, Vol.10 (3), p.483

2021

Volltextzugriff (PDF)

Impact of lockdown during the COVID-19 pandemic on health status in patients with cystic fibrosis: a mono-centre observational study

ERJ open research, 2022-01, Vol.8 (1), p.588

2022

Volltextzugriff (PDF)

Contrast agent-free functional magnetic resonance imaging with matrix pencil decomposition to quantify abnormalities in lung perfusion and ventilation in patients with cystic fibrosis

Frontiers in medicine, 2024-06, Vol.11, p.1349466

2024

Volltextzugriff (PDF)

Mukoviszidose im Kindes- und im Erwachsenenalter

Innere Medizin (Heidelberg, Germany), 2024, Vol.65 (6), p.538-544

2024

Volltextzugriff (PDF)

Optimal treatment of the underlying aetiology is the most effective antimicrobial stewardship for chronic respiratory disease: a lesson learned from cystic fibrosis

ERJ open research, 2023-07, Vol.9 (4), p.356

2023

Volltextzugriff (PDF)

Klinisches Bild der Lungenerkrankung bei zystischer Fibrose

Radiologe, 2020-09, Vol.60 (9), p.774-780

Stahl, Mirjam

2020

Volltextzugriff (PDF)

1 – 25 von 144

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(100)
Mit Volltextzugriff
(136)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(104)
Deutsch
(42)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

beängstigend und Wunderbar Zugleich: Erschütternde Ereignisse und Die Religionsaffinität der Neuen Erlebnisweise

Die Goldenen Zwanziger der Mukoviszidose

Magnetic Resonance Imaging Detects Changes in Structure and Perfusion, and Response to Therapy in Early Cystic Fibrosis Lung Disease

Lung collagens perpetuate pulmonary fibrosis via CD204 and M2 macrophage activation

Comparison of microbiomes from different niches of upper and lower airways in children and adolescents with cystic fibrosis

Sensitive markers to detect progression of lung disease in children with cystic fibrosis

Chronic but not intermittent infection with Pseudomonas aeruginosa is associated with global changes of the lung microbiome in cystic fibrosis

What to expect of the first ERS/ECFS Adult Cystic Fibrosis Conference

Antigen specificity and cross-reactivity drive functionally diverse anti-Aspergillus fumigatus T cell responses in cystic fibrosis

Quantification of Phenotypic Variability of Lung Disease in Children with Cystic Fibrosis

The value of chest magnetic resonance imaging compared to chest radiographs with and without additional lung ultrasound in children with complicated pneumonia

A multi-centre, randomized, controlled trial on coaching and telemonitoring in patients with cystic fibrosis: conneCT CF

Sustained Improvement of Cystic Fibrosis Lung Disease following Initiation of Elexacaftor/Tezacaftor/Ivacaftor Therapy: Lessons from Real-World Studies

Changes in Microbiome Dominance Are Associated With Declining Lung Function and Fluctuating Inflammation in People With Cystic Fibrosis

Effects of lumacaftor-ivacaftor therapy on cystic fibrosis transmembrane conductance regulator function in F508del homozygous patients with cystic fibrosis aged 2-11 years

Valsalva purpura after gastroscopy

Long-term effects of lumacaftor/ivacaftor on paranasal sinus abnormalities in children with cystic fibrosis detected with magnetic resonance imaging

A Volatile and Dynamic Longitudinal Microbiome Is Associated With Less Reduction in Lung Function in Adolescents With Cystic Fibrosis

Comparison of Oropharyngeal Microbiota from Children with Asthma and Cystic Fibrosis

CFTR Modulator Therapy with Lumacaftor/Ivacaftor Alters Plasma Concentrations of Lipid-Soluble Vitamins A and E in Patients with Cystic Fibrosis

Impact of lockdown during the COVID-19 pandemic on health status in patients with cystic fibrosis: a mono-centre observational study

Contrast agent-free functional magnetic resonance imaging with matrix pencil decomposition to quantify abnormalities in lung perfusion and ventilation in patients with cystic fibrosis

Mukoviszidose im Kindes- und im Erwachsenenalter

Optimal treatment of the underlying aetiology is the most effective antimicrobial stewardship for chronic respiratory disease: a lesson learned from cystic fibrosis

Klinisches Bild der Lungenerkrankung bei zystischer Fibrose

Suchergebnisse filtern